Newheenetow, i was very much interested in Ariad when ponatinib, the molecule, was the story. I will get interested again when 113, the molecule, becomes the story. Zero interest in waiting for ponatinib revenues now.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.